Killian John T, Lane Jane B, Cutter Gary R, Skinner Steven A, Kaufmann Walter E, Tarquinio Daniel C, Glaze Daniel G, Motil Kathleen J, Neul Jeffrey L, Percy Alan K
School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Civitan International Research Center, University of Alabama at Birmingham, Birmingham, Alabama.
Pediatr Neurol. 2014 Dec;51(6):769-75. doi: 10.1016/j.pediatrneurol.2014.08.013. Epub 2014 Aug 29.
Rett syndrome is a unique neurodevelopmental disorder, affecting approximately one in 10,000 live female births, most experiencing reduced growth. We characterized pubertal trajectories in females with Rett syndrome. We hypothesized that pubertal trajectory deviates from the general female population with early pubertal onset and delayed menarche.
Participants were individuals enrolled in the Rett Syndrome Natural History Study with clinical diagnosis of Rett syndrome or mutations in MECP2. Intervals to thelarche, adrenarche, and menarche were assessed by survival analysis; body mass index, mutation type, clinical severity, and pubertal milestone relationships were assessed by log-likelihood test; pathway synchrony (relationship between thelarche, adrenarche, and menarche) was assessed by chi-squared analysis.
Compared with the general female population, more than 25% initiated puberty early, yet entered menarche later (median age 13.0 years). A total of 19% experienced delayed menarche. Median length of puberty, from thelarche to menarche, was 3.9 years. Higher body mass index correlated with earlier thelarche and adrenarche but not menarche; milder mutations correlated with earlier menarche; and milder clinical presentation correlated with earlier thelarche and menarche. Fifty-two percent entered puberty in synchrony, but different from the general population, 15% led with thelarche and 32% with adrenarche.
Pubertal trajectories in Rett syndrome differ from general population, entering puberty early and reaching menarche later. Body mass index affects pubertal timing, but the relationship between specific mutations, clinical presentation, and underlying neuroendocrine pathology is less clear.
雷特综合征是一种独特的神经发育障碍,在每10000例存活女婴中约有1例患病,大多数患者生长发育迟缓。我们对雷特综合征女性患者的青春期发育轨迹进行了特征描述。我们假设雷特综合征女性患者的青春期发育轨迹与一般女性人群不同,青春期开始较早但初潮延迟。
研究对象为参加雷特综合征自然史研究且临床诊断为雷特综合征或存在MECP2基因突变的个体。通过生存分析评估乳房发育、肾上腺皮质功能初现和初潮的间隔时间;通过对数似然检验评估体重指数、突变类型、临床严重程度和青春期发育里程碑之间的关系;通过卡方分析评估发育途径同步性(乳房发育、肾上腺皮质功能初现和初潮之间的关系)。
与一般女性人群相比,超过25%的患者青春期开始较早,但初潮较晚(中位年龄13.0岁)。共有19%的患者初潮延迟。从乳房发育到初潮的青春期中位时长为3.9年。较高的体重指数与较早的乳房发育和肾上腺皮质功能初现相关,但与初潮无关;较轻的突变与较早的初潮相关;较轻的临床表现与较早的乳房发育和初潮相关。52%的患者青春期发育同步,但与一般人群不同的是,15%以乳房发育为先,32%以肾上腺皮质功能初现为先。
雷特综合征患者的青春期发育轨迹与一般人群不同,青春期开始较早但初潮较晚。体重指数影响青春期发育时间,但特定突变、临床表现与潜在神经内分泌病理之间的关系尚不清楚。